ESR1 and cancer: In this study we have, for the first time, demonstrated that ERα and ERβ5 proteins are co-expressed in endometrial adenocarcinomas with evidence that most epithelial cells in stage I cancers were immunopositive for ERβ5 but with variable expression of ERα.